Vertex Pharmaceuticals Incorporated Website

Vertex Pharmaceuticals Incorporated

NasdaqGS-VRTX

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Operating Revenues

4,160.7

6,202.8

7,573.4

8,930.7

9,869.2

10,337.4

Other Revenues, Total

—

—

—

—

—

2.1

2.9

1

—

—

—

Total Revenues

4,162.8

6,205.7

7,574.4

8,930.7

9,869.2

10,337.4

Total Revenues % Chg.

36.6%

49.1%

22.1%

17.9%

10.5%

8.8%

Cost of Goods Sold, Total

2,302.3

2,381.2

2,842

3,607.6

4,425.1

4,791.5

Gross Profit

1,860.5

3,824.5

4,732.4

5,323.1

5,444.1

5,545.9

Selling General & Admin Expenses, Total

658.5

770.5

840.1

944.7

1,136.6

1,347.8

Other Operating Expenses, Total

658.5

770.5

840.1

944.7

1,136.6

1,347.8

Operating Income

1,202

3,054

3,892.3

4,378.4

4,307.5

4,198.1

Interest Expense, Total

-58.5

-58.2

-61.5

-54.8

-44.1

-41.8

Interest And Investment Income

—

—

—

63.7

22.2

4.9

144.6

614.7

685.1

Net Interest Expenses

5.2

-36

-56.6

89.8

570.6

643.3

Currency Exchange Gains (Loss)

-5.2

-16.1

-13.9

-15.1

-24.6

-44.6

Other Non Operating Income (Expenses)

-0.2

0.8

1.7

-0.6

9.3

-13.4

EBT, Excl. Unusual Items

1,201.8

3,002.7

3,823.5

4,452.5

4,862.8

4,783.4

Restructuring Charges

—

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

—

—

—

197.6

311.9

17.1

-149.1

-7.5

-22

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

—

—

—

—

Asset Writedown

—

—

—

—

—

—

—

-13

—

—

In Process R&D Expenses

—

—

—

—

—

-184.6

-1,113.3

-115.5

-527.1

-4,595.4

Other Unusual Items

—

—

—

—

-4.5

-13.1

3.1

57.5

51.6

48.7

EBT, Incl. Unusual Items

1,394.9

3,116.9

2,730.4

4,232.4

4,379.8

214.7

Income Tax Expense

218.1

405.2

388.3

910.4

760.2

704.6

Earnings From Continuing Operations

1,176.8

2,711.7

2,342.1

3,322

3,619.6

-489.9

Earnings Of Discontinued Operations

—

—

—

—

—

—

—

—

—

—

Minority Interest

—

—

—

—

—

—

Net Income

1,176.8

2,711.7

2,342.1

3,322

3,619.6

-489.9

Preferred Dividend and Other Adjustments

—

—

—

—

—

—

—

—

—

Net Income to Common Incl Extra Items

1,176.8

2,711.7

2,342.1

3,322

3,619.6

-489.9

Net Income to Common Excl. Extra Items

1,176.8

2,711.7

2,342.1

3,322

3,619.6

-489.9

Total Shares Outstanding

259

259.9

254.5

257

257.7

258

Weighted Avg. Shares Outstanding

256.7

259.8

257.7

256.1

257.7

258

Weighted Avg. Shares Outstanding Dil

260.7

263.4

259.9

259.1

260.5

258

EPS

4.6

10.4

9.1

13

14

-1.9

EPS Diluted

4.5

10.3

9

12.8

13.9

-1.9

EBITDA

1,308.9

3,163.5

4,017.9

4,526.7

4,477

4,394.9

Effective Tax Rate

15.6%

13%

14.2%

21.5%

17.4%

328.2%